Atea Pharmaceuticals Inc (AVIR)

Total Costs & Expenses

$35.10M

Quarterly · Period ending: · USD

AVIR logo

AVIR Total Costs & Expenses

Latest reported$35.10M
AVIR Quarterly Total Costs & Expenses ($2.37M → $35.10M)
High-resolution chart · PNG

AVIR total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
35,099,000
48,008,000
54,934,000
45,567,000
41,345,000
39,041,000
39,026,000
37,202,000
46,916,000
69,806,000
46,573,000
40,785,000
35,235,000
41,569,000
39,899,000
16,281,000
32,295,000
42,175,000
70,999,000
54,958,000
51,704,000
35,330,000
27,986,000
17,629,000
10,003,000
4,045,000
4,749,000
3,769,000
3,718,000
2,372,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.